【Webinar】 Model Informed Drug Development: Application to Project Optimus (with video)

Discover a groundbreaking webinar delving into the application of model informed drug development (MIDD) in oncology to support dose selection. The Food and Drug Administration’s (FDA) increased recommendations for oncology dose justification beyond maximum tolerated dose (MTD) have increased interest in quantitative methods and their application to oncology.

This webinar will review the updated recommendations and overview the platform of tools used for MIDD so that attendees can design their experimental path to ensure they gather appropriate and sufficient data to inform pharmacometrics modeling and increase the scientific justification of their dose selection for first-in human (FIH) to pivotal studies.

Watch this webinar to gain insights into how to use model informed drug development in oncology to support dose selection in agreement with the FDA’s Project Optimus Goals.

Want to learn more?